Titan Pharmaceuticals (FRA:TN70) Days Sales Outstanding : 0.00 (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Titan Pharmaceuticals Days Sales Outstanding?

Titan Pharmaceuticals's average Accounts Receivable for the three months ended in Mar. 2024 was €0.08 Mil. Titan Pharmaceuticals's Revenue for the three months ended in Mar. 2024 was €0.00 Mil.

The historical rank and industry rank for Titan Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

FRA:TN70' s Days Sales Outstanding Range Over the Past 10 Years
Min: 55.64 Med: 590.09 Max: 16279
Current: 16279

During the past 13 years, Titan Pharmaceuticals's highest Days Sales Outstanding was 16279.00. The lowest was 55.64. And the median was 590.09.

FRA:TN70's Days Sales Outstanding is ranked worse than
99.55% of 883 companies
in the Biotechnology industry
Industry Median: 72.66 vs FRA:TN70: 16279.00

Titan Pharmaceuticals's Days Sales Outstanding stayed the same from Mar. 2023 (0.00) to Mar. 2024 (0.00).

Titan Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Titan Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Titan Pharmaceuticals Days Sales Outstanding Chart

Titan Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

1,234.45

461.81

685.20

425.83

13,870.00

Titan Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															-	684.38	-	-	-

Competitive Comparison of Titan Pharmaceuticals's Days Sales Outstanding

For the Biotechnology subindustry, Titan Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Titan Pharmaceuticals's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Titan Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Titan Pharmaceuticals's Days Sales Outstanding falls into.

Titan Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Titan Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.034	+	0.042)	/	2 )	/	0.001	*	365
=	0.038					/	0.001	*	365
=	13,870.00

Titan Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0.042	+	0.123)	/	2 )	/	0	*	365 / 4
=	0.0825					/	0	*	365 / 4
=	N/A

Titan Pharmaceuticals (FRA:TN70) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Titan Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Titan Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Titan Pharmaceuticals (FRA:TN70) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Titan Pharmaceuticals Inc (FRA:TN70) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

TTNP:USA

Address

400 Oyster Point Boulevard, Suite 505, South San Francisco, CA, USA, 94080

Website

https://www.titanpharm.com

Titan Pharmaceuticals Inc is a pharmaceutical company developing therapeutics utilizing its proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases for which steady state delivery of a drug provides efficacy and/or safety benefit. ProNeura consists of a small, solid implant made from a mixture of ethylene-vinyl acetate, or EVA, and a drug substance. Its first product based on ProNeura technology was the Probuphine (buprenorphine) implant, which was approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder in clinically stable patients taking 8 mg or less a day of oral buprenorphine.

Titan Pharmaceuticals (FRA:TN70) Headlines

No Headlines